Intradermal granulocyte - Macrophage colony-stimulating factor alters cutaneous antigen-presenting cells and differentially affects local versus distant immunization in humans

Clinical Immunology

Volumn 96, Issue 1, 2000, Pages 29-37

  Kremer, Inger B ^a   Stevens, Seth R ^a,b   Gould, Jennifer W ^a   Dicarlo, Joanne ^a   Quinby, Gary E ^a   Cooper, Kevin D ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Delayed type hypersensitivity; Dendritic cells; Growth factors; Human clinical studies; Skin

Indexed keywords

CD1 ANTIGEN; CD40 ANTIGEN; CD68 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL DIFFERENTIATION; CELL STRUCTURE; CONTACT SENSITIZATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNIZATION; LANGERHANS CELL; MACROPHAGE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033939916     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4876     Document Type: Article

References (34)

1. Donahue R. E., Wang E. A., Stone D. K., Kamen R., Wong G. G., Sehgal P. K., Nathan D. G., Clark S. C. Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature. 321:1986;872-875.
2. Metcalf D., Begley C. G., Williamson D. J., Nice E. C., De Lamarter J., Mermod J. J., Thatcher D., Schmidt A. Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp. Hematol. 15:1987;1-9.
3. Antman K. S., Griffin J. D., Elias A., Socinski M. A., Ryan L., Cannistra S. A., Oette D., Whitley M., Frei E., Schnipper L. E. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N. Engl. J. Med. 319:1988;593-598.
4. Herrmann F., Schulz G., Wieser M., Kolbe K., Nicolay U., Noack M., Lindemann A., Mertelsmann R. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy. Am. J. Med. 88:1990;619-624.
5. Smith C. H., Allen M. H., Groves R. W., Barker J. N. Effect of granulocyte macrophage-colony stimulating factor on Langerhans cells in normal and healthy atopic subjects. Br. J. Dermatol. 139:1998;239-246.
6. Brandt S. J., Peters W. P., Atwater S. K., Kurtzberg J., Borowitz M. J., Jones R. B., Shpall E. J., Bast R. C., Gilbert C. J., Oette D. H. Effect of recombinant human granulocyte-macrophage colony stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N. Engl. J. Med. 318:1988;869-876.
7. Ganser A., Volkers B., Greher J., Ottmann O. G., Walther F., Becher R., Bergmann L., Schulz G., Hoelzer D. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes - A phase I/II trial. Blood. 73:1989;31-37.
8. Vadhan R., Buescher S., Broxmeyer H. E., LeMaistre A., Lepe Z., Ventura G., Jega S., Horwitz L. J., Trujillo J. M., Gillis S., Hittelman W. N., Gutterman J. U. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. N. Engl. J. Med. 319:1988;1628-1634.
9. Groopman J. E., Mitsuyasu R. T., DeLeo M. J., Oette D. H., Golde D. W. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N. Engl. J. Med. 317:1987;593-598.
10. Pluda J. M., Yarchoan R., Smith P. D., McAtee N., Shay L. E., Oette D., Maha M., Wahl S. M., Myers C. E., Broder S. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. Blood. 76:1990;463-472.
11. Morrissey P. J., Bressler L., Park L. S., Alpert A., Gillis S. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J. Immunol. 139:1987;1113-1119.
12. Smith P. D., Lamerson C. L., Wong H. L., Wahl L. M., Wahl S. M. Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function. J. Immunol. 144:1990;3829-3834.
13. Grabstein K. H., Urdal D. L., Tushinski R. J., Mochizuki D. Y., Price V. L., Cantrell M. A., Gillis S., Conlon P. J. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science. 232:1986;506-508.
14. Coleman D. L., Chodakewitz J. A., Bartiss A. H., Mellors J. W. Granulocyte-macrophage colony-stimulating factor enhances selective effector functions of tissue-derived macrophages. Blood. 72:1988;573-578.
15. Steinman R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:1991;271-296.
16. Romani N., Koide S., Crowley M., Witmer-Pack M., Livingstone A. M., Fathman C. G., Inaba K., Steinman R. M. Presentation of exogenous protein antigens by dendritic cells to T cell clones. J. Exp. Med. 169:1989;1169-1178.
17. Schuler G., Steinman R. M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161:1985;526-546.
18. Witmer-Pack M., Olivier W., Valinsky J., Schuler G., Steinman R. M. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med. 166:1987;1484-1498.
19. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1994;1109-1118.
20. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature. 360:1992;258-261.
21. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R. M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1992;1693-1702.
22. Disis M. L., Bernhard H., Shiota F. M., Hand S. L., Gralow J. R., Huseby E. S., Gillis S., Cheever M. A. Granulocyte-macrophage colony-stimulating factor: An effective adjuvant for protein and peptide-based vaccines. Blood. 88:1996;202-210.
23. Dranoff G., Jaffee E., Lazenby A., Golumbek P., Levitsky H., Brose K., Jackson V., Hamada H., Pardoll D., Mulligan R. C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA. 90:1993;3539-3543.
24. Soiffer, R., Lynch, T., Mihm, M., Jung, K., Rhuda, C., Schmollinger, J. C., Hodi, F. S., Liebster, L., Lam, P., Mentzer, S., Singer, S., Tanabe, K. K., Cosimi, A. B., Dida, R., Sober, A., Bhan, A., Daley, J., Neuberg, D., Parry, G., Rokovich, J., Richards, L., Drayer, J., Berns, A., Clift, S., Cohen, L. K., Mulligan, R. C., and Dranoff, G., Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA95, 13141-13146, 1998.
25. Jager E., Ringhoffer M., Dienes H. P., Arand M., Karbach J., Jager D., Ilsemann C., Hagedorn M., Oesch F., Knuth A. Granulocyte-macrophage colony stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int. J. Cancer. 67:1996;54-62.
26. Armstrong C. A., Botella R., Galloway T. H., Murray N., Kramp J. M., Song I. S., Ansel J. C. Antitumor effects of granulocyte-macrophage colonystimulating factor production by melanoma cells. Cancer Res. 56:1996;2191-2198.
27. Kwak L. W., Young H. A., Pennington R. W., Weeks S. D. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response. Proc. Natl. Acad. Sci. USA. 93:1996;10972-10977.
28. Nestle F. O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4:1998;328-332.
29. Cooper K. D., Oberhelman L., Hamilton T. A., Baadsgaard O., Terhune M., LeVee G., Anderson T., Koren H. UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: Relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc. Natl. Acad. Sci. USA. 89:1992;8497-8501.
30. Heufler C., Koch F., Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin-1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med. 167:1988;700-705.
31. Kaplan G., Walsh G., Guido L. S., Meyn P., Burkhardt R. A., Abalos R. M., Barker J., Frindt P. A., Fajardo T. T., Celona R., Cohn Z. A. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J. Exp. Med. 175:1992;1717-1728.
32. Yoshikawa T., Rae V., Bruins-Slot W., Van den Berg J. W., Taylor J. R., Streilein J. W. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J. Invest. Dermatol. 95:1990;530-536.
33. Baadsgaard O., Lisby S., Wantzin G. L., Wulf H. C., Cooper K. D. Rapid recovery of Langerhans cell alloreactivity, without induction of autoreactivity, after in vivo ultraviolet A, but not ultraviolet B exposure of human skin. J. Immunol. 142:1989;4213-4218.
34. - T cell activation. Eur. J. Immunol. 28:1998;2936-2946.